Robert L. Ferrara - 14 Jun 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
14 Jun 2023
Net transactions value
+$6,200
Form type
4
Filing time
15 Jun 2023, 17:00:13 UTC
Previous filing
22 Feb 2023
Next filing
12 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $6,200 +2,000 +50% $3.10 6,000 14 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.